Community Bank & Trust Waco Texas acquired a new position in shares of Medtronic plc. (NYSE:MDT) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 5,107 shares of the medical technology company’s stock, valued at approximately $412,000.
Other institutional investors also recently made changes to their positions in the company. Trust Co. of Toledo NA OH increased its holdings in shares of Medtronic by 6.4% during the 2nd quarter. Trust Co. of Toledo NA OH now owns 11,030 shares of the medical technology company’s stock worth $979,000 after acquiring an additional 664 shares during the last quarter. Fisher Asset Management LLC increased its holdings in shares of Medtronic by 2,485.0% during the 2nd quarter. Fisher Asset Management LLC now owns 183,765 shares of the medical technology company’s stock worth $16,309,000 after acquiring an additional 176,656 shares during the last quarter. Somerset Trust Co increased its holdings in shares of Medtronic by 3.8% during the 2nd quarter. Somerset Trust Co now owns 59,523 shares of the medical technology company’s stock worth $5,283,000 after acquiring an additional 2,201 shares during the last quarter. Howe & Rusling Inc. increased its holdings in shares of Medtronic by 3.4% during the 2nd quarter. Howe & Rusling Inc. now owns 84,035 shares of the medical technology company’s stock worth $7,458,000 after acquiring an additional 2,725 shares during the last quarter. Finally, Liberty Capital Management Inc. increased its holdings in shares of Medtronic by 9.5% during the 2nd quarter. Liberty Capital Management Inc. now owns 2,311 shares of the medical technology company’s stock worth $202,000 after acquiring an additional 200 shares during the last quarter. Institutional investors own 81.75% of the company’s stock.
A number of research analysts recently weighed in on the company. Stifel Nicolaus boosted their target price on Medtronic from $83.00 to $85.00 and gave the stock a “hold” rating in a report on Wednesday, November 22nd. SunTrust Banks reissued a “buy” rating and set a $96.00 target price on shares of Medtronic in a report on Friday, November 3rd. BMO Capital Markets reissued an “outperform” rating and set a $89.00 target price (down from $92.00) on shares of Medtronic in a report on Tuesday, October 10th. Needham & Company LLC decreased their target price on Medtronic from $95.00 to $94.00 and set a “buy” rating on the stock in a report on Tuesday, October 10th. Finally, Oppenheimer reissued a “buy” rating and set a $94.00 target price on shares of Medtronic in a report on Wednesday, November 22nd. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and fifteen have given a buy rating to the company’s stock. Medtronic presently has an average rating of “Buy” and a consensus price target of $89.65.
In other news, EVP Bryan C. Hanson sold 16,000 shares of the stock in a transaction on Friday, December 15th. The stock was sold at an average price of $82.82, for a total transaction of $1,325,120.00. Following the sale, the executive vice president now directly owns 88,818 shares of the company’s stock, valued at approximately $7,355,906.76. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, VP Richard Kuntz sold 78,526 shares of the stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $86.21, for a total value of $6,769,726.46. Following the sale, the vice president now directly owns 149,761 shares in the company, valued at $12,910,895.81. The disclosure for this sale can be found here. Over the last three months, insiders have sold 136,684 shares of company stock worth $11,582,596. 0.31% of the stock is currently owned by insiders.
Medtronic plc. (NYSE MDT) opened at $87.26 on Friday. The company has a quick ratio of 2.05, a current ratio of 2.40 and a debt-to-equity ratio of 0.50. Medtronic plc. has a 1-year low of $73.59 and a 1-year high of $89.72. The company has a market capitalization of $116,550.00, a price-to-earnings ratio of 23.97, a price-to-earnings-growth ratio of 2.35 and a beta of 0.99.
Medtronic (NYSE:MDT) last issued its quarterly earnings data on Tuesday, November 21st. The medical technology company reported $1.07 EPS for the quarter, beating analysts’ consensus estimates of $0.99 by $0.08. The firm had revenue of $7.05 billion for the quarter, compared to analyst estimates of $7.05 billion. Medtronic had a return on equity of 12.63% and a net margin of 16.93%. The company’s revenue for the quarter was down 4.0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.12 EPS. equities research analysts predict that Medtronic plc. will post 4.77 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, January 19th. Stockholders of record on Friday, December 29th will be issued a dividend of $0.46 per share. This represents a $1.84 annualized dividend and a dividend yield of 2.11%. The ex-dividend date of this dividend is Thursday, December 28th. Medtronic’s dividend payout ratio (DPR) is currently 50.55%.
ILLEGAL ACTIVITY WARNING: “Community Bank & Trust Waco Texas Takes Position in Medtronic plc. (MDT)” was originally published by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this story can be viewed at https://www.truebluetribune.com/2018/01/19/community-bank-trust-waco-texas-takes-position-in-medtronic-plc-mdt.html.
Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.
Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.